title: Somatostatin receptor scintigraphy in medullary thyroid carcinoma.
abstract: BACKGROUND
  111In-radiolabelled (DTPA-D-Phe1)-octreotide scintigraphy can be used to localize neuroendocrine tumours expressing somatostatin receptors (SSTRs). The aim of this paper was to analyse the importance of tumour volume and growth for the visualization by SSTR scintigraphy of metastases from medullary thyroid carcinoma (MTC).
  
  
  METHODS
  Serum calcitonin concentrations were used to estimate volume and growth rate of MTC. Twenty-two patients who had persistent hypercalcitoninaemia after total thyroidectomy for MTC, indicating the presence of metastases, were studied.
  
  
  RESULTS
  SSTR scintigraphy visualized 15 tumours in 11 patients. Patients with scintigraphically visualized tumours had higher serum calcitonin and carcinoembryonic antigen concentrations and larger tumours, and the serum calcitonin concentration increased more rapidly with time. Tumour-associated symptoms and death from MTC occurred only in patients with scintigraphically visualized tumours.
  
  
  CONCLUSIONS
  Scintigraphically visualized tumours grow more rapidly and are more aggressive than nonvisualized lesions. SSTR scintigraphy can be helpful in the planning of palliative surgery for MTC and for diagnosing distant metastases, but cannot localize microscopic metastases.
authors.affiliation: Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden.
authors.forename: L E
authors.initials: LE
authors.lastname: Tisell
authors.forename: H
authors.initials: H
authors.lastname: Ahlman
authors.forename: B
authors.initials: B
authors.lastname: Wängberg
authors.forename: G
authors.initials: G
authors.lastname: Hansson
authors.forename: J
authors.initials: J
authors.lastname: Mölne
authors.forename: O
authors.initials: O
authors.lastname: Nilsson
authors.forename: G
authors.initials: G
authors.lastname: Lindstedt
authors.forename: M
authors.initials: M
authors.lastname: Fjälling
authors.forename: E
authors.initials: E
authors.lastname: Forssell-Aronsson
mesh_terms: D015152:Blotting, Northern; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D018813:Multiple Endocrine Neoplasia Type 2a / Q000150:complications; D015282:Octreotide / Q000031:analogs & derivatives; D004369:Pentetic Acid / Q000031:analogs & derivatives; D011877:Radionuclide Imaging; D017481:Receptors, Somatostatin / Q000378:metabolism*; D013964:Thyroid Neoplasms / Q000150:complications / Q000000981:diagnostic imaging* / Q000473:pathology; D013965:Thyroidectomy
chemical_list: D017481:Receptors, Somatostatin; C071632:SDZ 215-811; D004369:Pentetic Acid; D015282:Octreotide